brain tumor

(Canale Communications) Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.

Almost all mice receiving the top dose of Toca 511 followed by 5-FC were still alive at 180 days, which was the termination date for the experiment, whereas all control mice died by day 43.

The article was published today in the February issue of the Neuro-Oncology journal.

Jessica Alonso always knew she was going to college. Her doctors weren’t as sure. The Queens College freshman has spent most of her teen life in and out of hospitals recovering from a brain tumor — a fight that at one point left her unable to talk or swallow food.

(Edelman Public Relations) Novocure, a commercial stage private oncology company, has announced that prominent neuro-oncologists at four clinical centers in the US will be the first to provide access to its Tumor Treating Fields device, NovoTTF-100A System, for the treatment of recurrent glioblastoma multiforme (GBM).

GBM is a deadly brain tumor affecting approximately 10,000 Americans each year.

(University of California - San Francisco) Brain tumor specimens taken from neurosurgery cases at the University of California, San Francisco, Medical Center has given scientists a new window on the transformation that occurs as healthy brain cells begin to form tumors.

Jesus Barrios was shot twice in the head, with one bullet passing through and leaving staple-sized fragments in his brain.

He faced a future of seizures, infection, and vision loss because it's too risky to remove the specks.

An expert panel has advised the FDA to approve a new kind of device to treat recurrent glioblastoma, an aggressive and highly fatal kind of brain tumor.

(MedPage Today) -- There may be one benefit to having a lot of allergies -- they may protect against glioma, researchers found.

Drinking about a half cup or more of coffee or tea per day is associated with a 34% reduction in the risk for glioma, a type of brain tumor, researchers report.

(Emory University) Tiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells.

In mice, researchers have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging.

(Ohio State University Medical Center) High energy levels cause glioblastoma cells to proliferate; low levels cause them to grow less and to migrate.

This study discovered that a molecule called miR-451 coordinates this grow-or-go behavior, which is closely linked to the cells' ability to invade and spread.

Thus, the molecule might be a biomarker for predicting survival in patients with glioblastoma multiforme and may serve as a target to develop drugs to fight these tumors.